Shift Bioscience is unlocking safe rejuvenation with cell simulations. Cellular reprogramming is a powerful biological pathway that can reverse ageing and age-driven diseases in the dish but is not yet safe for clinical use. Our team based in Cambridge UK has pioneered the first high throughput, high accuracy ageing biomarker, which can be leveraged in AI-based cell simulations to identify drug targets for safe rejuvenation.

AI/ML

Biotechnology

Health Care

Health Diagnostics

Life Sciences

Shift Bioscience

Shift Bioscience's headquarters in Cambridge, United Kingdom

Description

People (4)

Brendan Swain

Leonard Wossnig

Lucas Paulo de Lima Camillo

Rejina Khan

Jobs